5-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. Its short duration –from 20 minutes to one hour– is giving ...

Small Pharma is leading the most advanced clinical study in commercial development of DMT-based therapies. CEO Peter Rands says the company "is taking a radically different approach to mental health ...

Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with effects lasting up to six months.

Entering the field of psychedelic therapy, whether as a therapist or a client, means learning about an ever-growing, sometimes bewildering array of psychedelic substances. My friends in the field have ...

Study finds participants saw reduction in depressive symptoms as researchers welcome ‘promising’ results A phase II clinical trial has found dimethyltryptamine (DMT), one of the psychoactive ...

Cosmo Feilding-Mellen is the co-founder and CEO at Beckley Psytech, a UK-based biotech company developing psychedelic compounds. Based on a growing body of clinical research, psychedelic-assisted ...